SEC Form 4 · accession 0001209191-15-072080

VERTEX PHARMACEUTICALS INC / MA · VRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Sep 23, 2015

Accepted (ET)

Sep 24, 2015 · 3:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000875320

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 23, 2015	M	10,400	$35.64	A	355,684	D
Common Stock^F2,F3	Sep 23, 2015	S	1,000	$109.09	D	354,684	D
Common Stock^F2,F4	Sep 23, 2015	S	1,200	$110.23	D	353,484	D
Common Stock^F2,F5	Sep 23, 2015	S	4,288	$111.35	D	349,196	D
Common Stock^F2,F6	Sep 23, 2015	S	1,310	$112.45	D	347,886	D
Common Stock^F2,F7	Sep 23, 2015	S	800	$113.37	D	347,086	D
Common Stock^F2,F8	Sep 23, 2015	S	1,300	$114.58	D	345,786	D
Common Stock^F2,F9	Sep 23, 2015	S	502	$115.34	D	345,284	D
Common Stock	holding	—	—		—	13,286	I	401(k)
Common Stock	holding	—	—		—	122,700	I	Common Stock held in trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F10	$35.64	Sep 23, 2015	M	10,400	D	—	Feb 1, 2016	Common Stock	10,400	188,000	D

F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
F10Fully vested.
F2Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3Open market sales reported on this line occurred at a weighted average price of $109.09 (range $108.58 to $109.50).
F4Open market sales reported on this line occurred at a weighted average price of $110.23 (range $109.75 to $110.59).
F5Open market sales reported on this line occurred at a weighted average price of $111.35 (range $110.88 to $111.86).
F6Open market sales reported on this line occurred at a weighted average price of $112.45 (range $112.00 to $112.86).
F7Open market sales reported on this line occurred at a weighted average price of $113.37 (range $113.00 to $113.82).
F8Open market sales reported on this line occurred at a weighted average price of $114.58 (range $114.20 to $114.95).
F9Open market sales reported on this line occurred at a weighted average price of $115.34 (range $115.25 to $115.40).